82 FR 17996 - Healthcare Infection Control Practices Advisory Committee (HICPAC)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 71 (April 14, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 71 (April 14, 2017)
| Page Range | 17996-17997 | |
| FR Document | 2017-07594 |
[Federal Register Volume 82, Number 71 (Friday, April 14, 2017)] [Notices] [Pages 17996-17997] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-07594] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) announces a meeting of the aforementioned committee: Time and Date: 1:00 p.m.-2:30 p.m., EDT, May 5, 2017. Place: This meeting will be accessible by teleconference. Toll-free +1 (888) 469-1070, Participant Code: 3132529. Status: Open to the public limited only by the availability of 200 telephone ports. To register for this call, please go to www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include a follow-up discussion on the Draft Recommendation Update for Chlorhexidine Impregnated Dressings. Call materials will be made available to the public no later than 2 business days [[Page 17997]] before the call. If CDC is unable to post the background material on the HICPAC site prior to the meeting, the background material will be posted on HICPAC's Web site after the meeting. Background material is available at http://www.cdc.gov/hicpac. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A-31, Atlanta, Georgia 30333; Email: [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-07594 Filed 4-13-17; 8:45 am] BILLING CODE 4163-18-P
![17996 Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices
Conducting Public Health Research in DEPARTMENT OF HEALTH AND Georgia 30329, telephone (404) 639–
South Africa; GH17–004, Conducting HUMAN SERVICES 8317; Email: zkr7@cdc.gov.
Public Health Research Activities in The Director, Management Analysis
Egypt. Centers for Disease Control and and Services Office, has been delegated
Prevention the authority to sign Federal Register
Summary: This publication corrects a
Notices pertaining to announcements of
notice that was published in the Federal Health Resources and Services meetings and other committee
Register on April 4, 2017, Volume 82, Administration management activities, for both the
Number 63, page 16403. The meeting Centers for Disease Control and
announcement, meeting date, and CDC/HRSA Advisory Committee on Prevention and the Agency for Toxic
matters for discussion should read as HIV, Viral Hepatitis and STD Prevention Substances and Disease Registry.
follows: and Treatment
Elaine L. Baker,
The meeting announced below In accordance with section 10(a)(2) of Director, Management Analysis and Services
concerns the Centers for Disease Control the Federal Advisory Committee Act Office, Centers for Disease Control and
and Prevention (CDC) initial review of (Pub. L. 92–463), the Centers for Disease Prevention.
applications in response to Funding Control and Prevention (CDC) and the [FR Doc. 2017–07593 Filed 4–13–17; 8:45 am]
Opportunity Announcements GH17– Health Resources and Services BILLING CODE 4163–18–P
002, Program Development and Administration (HRSA) announce the
Research to Establish and Evaluate following committee meeting.
Innovative and Emerging Best Practices Times and Dates: 8:30 a.m.–5:00 p.m., DEPARTMENT OF HEALTH AND
in Clinical and Community Services EDT, May 10, 2017; 8:30 a.m.–3:00 p.m., HUMAN SERVICES
through the President’s Emergency Plan EDT, May 11, 2017.
for AIDS Relief (PEPFAR); and GH17– Place: CDC Corporate Square, Centers for Disease Control and
003, Conducting Public Health Research Building 8, Conference Room 1–ABC, 8 Prevention
in South Africa. Corporate Boulevard, Atlanta, Georgia
Healthcare Infection Control Practices
Time and Date: 9:00 a.m.–2:00 p.m., 30329, Telephone: (404) 639–8317. The
Advisory Committee (HICPAC)
EDT, April 25, 2017, Panel A (Closed). meeting is also accessible by
teleconference. Toll-free number 1–877– In accordance with section 10(a)(2) of
Matters for Discussion: The meeting 603–4228, Participant code: 42598858. the Federal Advisory Committee Act
will include the initial review, Status: Open to the public, limited (Pub. L. 92–463), the Centers for Disease
discussion, and evaluation of only by the space available. The meeting Control and Prevention (CDC), National
applications received in response to room will accommodate approximately Center for Emerging and Zoonotic
‘‘Program Development and Research to 100 people. Persons who desire to make Infectious Diseases (NCEZID) announces
Establish and Evaluate Innovative and an oral statement, may request it at the a meeting of the aforementioned
Emerging Best Practices in Clinical and time of the public comment period on committee:
Community Services through the May 10, 2017 at 4:30 p.m., EDT. Public Time and Date: 1:00 p.m.–2:30 p.m.,
President’s Emergency Plan for AIDS participation and ability to comment EDT, May 5, 2017.
Relief (PEPFAR)’’, FOA GH17–002; and will be limited to space and time as it Place: This meeting will be accessible
‘‘Conducting Public Health Research in permits. by teleconference. Toll-free +1 (888)
South Africa’’, FOA GH17–003. Purpose: This committee is charged 469–1070, Participant Code: 3132529.
with advising the Director, CDC and the Status: Open to the public limited
For Further Information Contact: Administrator, HRSA, regarding only by the availability of 200 telephone
Hylan Shoob, Scientific Review Officer, activities related to prevention and ports. To register for this call, please go
Center for Global Health (CGH) Science control of HIV/AIDS, Viral Hepatitis and to www.cdc.gov/hicpac.
Office, CGH, CDC, 1600 Clifton Road other STDs, the support of health care Purpose: The Committee is charged
NE., Mailstop D–69, Atlanta, Georgia services to persons living with HIV/ with providing advice and guidance to
30033, Telephone: (404) 639–4796, AIDS, and education of health the Director, Division of Healthcare
HSHOOB@CDC.GOV. professionals and the public about HIV/ Quality Promotion, the Director,
The Director, Management Analysis AIDS, Viral Hepatitis and other STDs. National Center for Emerging and
and Services Office, has been delegated Matters for Discussion: Agenda items Zoonotic Infectious Diseases (NCEZID),
the authority to sign Federal Register include the following topics: (1) HIV the Director, CDC, the Secretary, Health
notices pertaining to announcements of transmission risk in the context of viral and Human Services regarding (1) the
meetings and other committee suppression and antiretroviral therapy practice of healthcare infection
management activities, for both the (ART) use; (2) Update on Pre-Exposure prevention and control; (2) strategies for
Prophylaxis (PrEP) utilization; (3) surveillance, prevention, and control of
Centers for Disease Control and
Vulnerable youth at risk for HIV, STDs, infections, antimicrobial resistance, and
Prevention and the Agency for Toxic
hepatitis, substance use and other related events in settings where
Substances and Disease Registry. health outcomes; (4) Eliminating healthcare is provided; and (3) periodic
Elaine L. Baker, hepatitis B and hepatitis C as public updating of CDC guidelines and other
Director, Management Analysis and Services health threats in the United States— policy statements regarding prevention
sradovich on DSK3GMQ082PROD with NOTICES
Office, Centers for Disease Control and Setting Goals and Taking Action; and (5) of healthcare-associated infections and
Prevention. Updates from Workgroups. Agenda healthcare-related conditions.
[FR Doc. 2017–07595 Filed 4–13–17; 8:45 am] items are subject to change as priorities Matters for Discussion: The agenda
dictate. will include a follow-up discussion on
BILLING CODE 4163–18–P
Contact Person for More Information: the Draft Recommendation Update for
Margie Scott-Cseh, Centers for Disease Chlorhexidine Impregnated Dressings.
Control and Prevention, 1600 Clifton Call materials will be made available to
Road NE., Mailstop E–07, Atlanta, the public no later than 2 business days
VerDate Sep<11>2014 16:21 Apr 13, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1](https://thefederalregister.org/doc/82_FR_18067/page/1.svg)
![Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices 17997
before the call. If CDC is unable to post the accuracy of the estimated burden, approval from the Office of Management
the background material on the HICPAC ways to enhance the quality, utility, and and Budget (OMB) for each collection of
site prior to the meeting, the background clarity of the information to be information they conduct or sponsor.
material will be posted on HICPAC’s collected, and the use of automated The term ‘‘collection of information’’ is
Web site after the meeting. Background collection techniques or other forms of defined in 44 U.S.C. 3502(3) and 5 CFR
material is available at http:// information technology to minimize the 1320.3(c) and includes agency requests
www.cdc.gov/hicpac. information collection burden. or requirements that members of the
Agenda items are subject to change as DATES: Comments must be received by public submit reports, keep records, or
priorities dictate. June 13, 2017. provide information to a third party.
Contact Person for More Information: ADDRESSES: When commenting, please Section 3506(c)(2)(A) of the PRA
Erin Stone, M.A., HICPAC, Division of reference the document identifier or requires federal agencies to publish a
Healthcare Quality Promotion, NCEZID, OMB control number. To be assured 60-day notice in the Federal Register
CDC, 1600 Clifton Road NE., Mailstop consideration, comments and concerning each proposed collection of
A–31, Atlanta, Georgia 30333; Email: recommendations must be submitted in information, including each proposed
HICPAC@cdc.gov. any one of the following ways: extension or reinstatement of an existing
The Director, Management Analysis 1. Electronically. You may send your collection of information, before
and Services Office, has been delegated comments electronically to http:// submitting the collection to OMB for
the authority to sign Federal Register www.regulations.gov. Follow the approval. To comply with this
notices pertaining to announcements of instructions for ‘‘Comment or requirement, CMS is publishing this
meetings and other committee Submission’’ or ‘‘More Search Options’’ notice.
management activities, for both the to find the information collection Information Collection
Centers for Disease Control and document(s) that are accepting
Prevention and the Agency for Toxic comments. 1. Type of Information Collection
Substances and Disease Registry. 2. By regular mail. You may mail Request: Extension of a currently
written comments to the following approved collection; Title of
Elaine L. Baker, Information Collection: Health
address: CMS, Office of Strategic
Director, Management Analysis and Services Insurance Benefit Agreement; Use:
Office, Centers for Disease Control and Operations and Regulatory Affairs,
Division of Regulations Development, Applicants to the Medicare program are
Prevention.
Attention: Document Identifier/OMB required to agree to provide services in
[FR Doc. 2017–07594 Filed 4–13–17; 8:45 am] accordance with federal requirements.
Control Number lll, Room C4–26–
BILLING CODE 4163–18–P
05, 7500 Security Boulevard, Baltimore, The CMS–1561/1561A is essential in
Maryland 21244–1850. that is allows us to ensure that
To obtain copies of a supporting applicants are in compliance with the
DEPARTMENT OF HEALTH AND requirements. Applicants will be
HUMAN SERVICES statement and any related forms for the
proposed collection(s) summarized in required to sign the completed form and
Centers for Medicare & Medicaid this notice, you may make your request provide operational information to us to
Services using one of following: assure that they continue to meet the
1. Access CMS’ Web site address at requirements after approval. Form
[Document Identifiers: CMS–1561/1561A, https://www.cms.gov/Regulations-and- Number: CMS–1561/1561A (OMB
CMS–370 and CMS–377, CMS–10488, and Guidance/Legislation/Paperwork control number: 0938–0832); Frequency:
CMS–10393] Yearly; Affected Public: Private sector—
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your (Business or other for-profits and Not-
Agency Information Collection
address, phone number, OMB number, for-profit institutions); Number of
Activities: Proposed Collection;
and CMS document identifier, to Respondents: 2,400; Total Annual
Comment Request
Paperwork@cms.hhs.gov. Responses: 2,400; Total Annual Hours:
AGENCY: Centers for Medicare & 3. Call the Reports Clearance Office at 400. (For policy questions regarding this
Medicaid Services, HHS. (410) 786–1326. collection contact Shonte Carter at 410–
ACTION: Notice. FOR FURTHER INFORMATION CONTACT: 786–3532).
William Parham at (410) 786–4669. 2. Type of Information Collection
SUMMARY: The Centers for Medicare & SUPPLEMENTARY INFORMATION: Request: Extension of a currently
Medicaid Services (CMS) is announcing approved collection; Titles of
an opportunity for the public to Contents Information Collection: ASC Forms for
comment on CMS’ intention to collect This notice sets out a summary of the Medicare Program Certification; Use:
information from the public. Under the use and burden associated with the The CMS–370 is used to establish
Paperwork Reduction Act of 1995 (the following information collections. More eligibility for payment. This agreement,
PRA), federal agencies are required to detailed information can be found in upon submission by the ambulatory
publish notice in the Federal Register each collection’s supporting statement surgical center (ASC) and acceptance for
concerning each proposed collection of and associated materials (see filing by the Secretary of Health &
information (including each proposed ADDRESSES). Human Services, shall be binding on
extension or reinstatement of an existing CMS–1561/1561A Health Insurance both the ASC and the Secretary. The
collection of information) and to allow Benefit Agreement agreement may be terminated by either
60 days for public comment on the
sradovich on DSK3GMQ082PROD with NOTICES
CMS–370 and CMS–377 ASC Forms party in accordance with regulations. In
proposed action. Interested persons are for Medicare Program Certification the event of termination, payment will
invited to send comments regarding our CMS–10488 Consumer Experience not be available for ASC services
burden estimates or any other aspect of Survey Data Collection furnished on or after the effective date
this collection of information, including CMS–10393 Beneficiary and Family of termination.
the necessity and utility of the proposed Centered Data Collection The Request for Certification or
information collection for the proper Under the PRA (44 U.S.C. 3501– Update of Certification Information in
performance of the agency’s functions, 3520), federal agencies must obtain the Medicare Program Form (CMS–377)
VerDate Sep<11>2014 16:21 Apr 13, 2017 Jkt 241001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1](https://thefederalregister.org/doc/82_FR_18067/page/2.svg)
Document Created: 2017-04-14 00:56:13
Document Modified: 2017-04-14 00:56:13
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 1:00 p.m.-2:30 p.m., EDT, May 5, 2017. | |
| FR Citation | 82 FR 17996 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR